1. Home
  2. TT vs BSX Comparison

TT vs BSX Comparison

Compare TT & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trane Technologies plc

TT

Trane Technologies plc

HOLD

Current Price

$462.51

Market Cap

94.1B

Sector

Industrials

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$64.59

Market Cap

93.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TT
BSX
Founded
1885
1979
Country
Ireland
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.1B
93.4B
IPO Year
2009
2010

Fundamental Metrics

Financial Performance
Metric
TT
BSX
Price
$462.51
$64.59
Analyst Decision
Buy
Strong Buy
Analyst Count
16
21
Target Price
$487.81
$102.19
AVG Volume (30 Days)
1.1M
14.5M
Earning Date
04-30-2026
04-22-2026
Dividend Yield
0.89%
N/A
EPS Growth
15.48
55.20
EPS
12.98
1.94
Revenue
$14,782,000,000.00
$9,076,000,000.00
Revenue This Year
$12.07
$11.91
Revenue Next Year
$8.04
$10.26
P/E Ratio
$36.36
$32.89
Revenue Growth
5.58
12.49
52 Week Low
$327.05
$60.59
52 Week High
$479.37
$109.50

Technical Indicators

Market Signals
Indicator
TT
BSX
Relative Strength Index (RSI) 60.98 41.37
Support Level $400.04 N/A
Resistance Level $470.55 $76.77
Average True Range (ATR) 12.05 1.77
MACD 5.52 0.41
Stochastic Oscillator 81.24 36.29

Price Performance

Historical Comparison
TT
BSX

About TT Trane Technologies plc

Trane Technologies manufactures and services commercial and residential HVAC systems and transportation refrigeration solutions under its prominent Trane, American Standard, and Thermo King brands. The company generates approximately 70% of sales from equipment and 30% from parts and services. While the firm is domiciled in Ireland, North America accounts for approximately 80% of its revenue, with 13% from EMEA and 7% Asia-Pacific. The company was formed in 2020 when its former parent, Ingersoll Rand, merged with Gardner Denver in a tax-advantaged reverse Morris trust transaction.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: